AssetMark’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
AssetMark's XERS Position: Q3 2026 in Review
AssetMark held its Xeris Biopharma Holdings (XERS) position steady in Q3 2026 at 177 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #3093.
AssetMark first reported a position in XERS in Q2 2026 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- AssetMark held 177 shares of Xeris Biopharma Holdings worth $1.69K as of Q3 2026.
- AssetMark left its Xeris Biopharma Holdings share count unchanged in Q3 2026.
- Xeris Biopharma Holdings made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3093 holding.
- AssetMark first reported a position in Xeris Biopharma Holdings in Q2 2026 and has held it in 2 quarters since.
- 182 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.